Back to results
US 2017/0283387 A1Published application
Metabolism probes for therapy and diagnosis
AssigneeVanderbilt University
InventorsH. Charles Manning, Michael Schulte
Life of this patent
Estimating the term…
Abstract
Novel 2-substituted glutamylanides useful as modulators of ASCT2 inhibitors. Compounds of the present invention can be used to treat patients suffering from diseases caused or influenced by abnormal ASCT2 transporter dysfunction.
Claims17
A compound of the following formula:
- wherein:
- R1 is a bond, optionally substituted C1-C6 alkyl, or optionally substituted SO2—(C1-C6 alkyl);
- R2 is optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heterocycle, or optionally substituted heterocycloalkyl;
- R3 is H or optionally substituted C1-C6 alkyl;
- and
- R4 is NH2 or NHBoc;
- or pharmaceutically acceptable salts or derivatives thereof.
4 more elements
Dependencies are inferred from the claim text.